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Haplotype analysis has been increasingly used to study the genetic basis of human dis-
eases, but models for characterizing genetic interactions between haplotypes from dif-
ferent chromosomal regions have not been well developed in the current literature. In
this article, we describe a statistical model for testing haplotype-haplotype interactions for
human diseases with a case-control genetic association design. The model is formulated
on a contingency table in which cases and controls are typed for the same set of mole-
cular markers. By integrating well-established quantitative genetic principles, the model
is equipped with a capacity to characterize physiologically meaningful epistasis arising
from interactions between haplotypes from different chromosomal regions. The model
allows the partition of epistasis into different components due to additive× additive, addi-
tive× dominance, dominance× additive, and dominance× dominance interactions. We
derive the EM algorithm to estimate and test the effects of each of these components
on differences in the pattern of genetic variation between cases and controls and, there-
fore, examine their role in the pathogenesis of human diseases. The method was further
extended to investigate gene-environment interactions expressed at the haplotype level.
The statistical properties of the models were investigated through simulation studies and
its usefulness and utilization validated by analyzing the genetic association of sarcoidosis
from a human genetics project.
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1. INTRODUCTION
One important aspect of the genetic complexity of human dis-
eases is that the effect of one gene depends on the expression of
one or more other genes, regulated by environmental and devel-
opmental signals (Martin et al., 2002; Gabutero et al., 2007).
Such dependence, called epistasis, is thought to pervade biolog-
ical kingdoms and play a pivotal role in determining the genetic
architecture of complex traits (Wu et al., 2004; Shao et al., 2008).
Because of increasing recognition of the importance of epista-
sis, there has been an explosive interest over the past 5 years in
modeling epistasis and estimating its effects on complex traits
and diseases (Marchini et al., 2005; Purcell et al., 2007; An et al.,
2009; Lambrechts, 2010; Wang et al., 2010; Wray and Goddard,
2010; Wu et al., 2010). With the continuous reduction of cost and
time to generate high-throughput genotyping data, the analysis
and detection of epistatic effects will become a routine proce-
dure for genetic association studies, particularly in genome-wide
association studies.
Most existing work of epistatic modeling focuses on the genetic
interactionbetween individual genes and its different components,
additive× additive, additive× dominance, dominance× additive,
and dominance× dominance components, originally deﬁned by
Fisher (1918). Early geneticists incorporated Fisher’s theory into
an experimental design by which gene-gene epistasis and its indi-
vidual components can be tested and estimated using statistical
models (Cockerham, 1954; Mather and Jinks, 1982). Epistatic
modeling has been implemented in genetic mapping derived from
an experimental cross or natural population, allowing the charac-
terization of epistatic effects on any complex trait (Kao and Zeng,
2002;Wu et al., 2004, 2006).More recently, several researchers have
incorporated epistasis into commonly used case-control genetic
association studies (Zhang and Liu, 2007; Gayan et al., 2008)
to accommodate the recent rapid development of genome-wide
association studies. Most of these studies focus on the statisti-
cal deﬁnition of epistasis, i.e., the deviation from additivity of
individual loci due to a non-linear relationship between multi-
locus genotypes and phenotypic variation in a population. This
so-called statistical epistasis is a population concept depending on
allele frequencies. In fact, epistasis has its own physiological mean-
ing, in which the mutual dependence of multiple genes results
from physiological interactions among biomolecules within gene
regulatory networks and biochemical pathways in an individual
(Cheverud and Routman, 1995; Moore and Williams, 2005).
In general, statistical epistasis can better be used in evolu-
tionary genetics and plant breeding for complex traits (Hallauer
et al., 2010), aimed to study the change of population means.
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Physiological epistasis is relevant to the medical genetics of com-
plex diseases, interested in genotypic values of every individual. Liu
et al. (2011) incorporated physiological epistasis into the contin-
gency table of a case-control designby embedding Fisher’s epistatic
deﬁnition (see also North et al., 2005). They have proved a favor-
able statistical property of epistatic test and showed increased
power to detect epistasis using a simple χ2 test. Wang et al.
(2010) derived a general model for analyzing epistasis of any num-
ber of genes in a case-control study, showing the importance of
high-order epistasis in genetic control of human diseases.
With the availability of HapMap data (The International
HapMap Consortium, 2003, 2005), a growing body of evi-
dence shows that haplotypes, i.e., a sequence of alleles for single
nucleotide polymorphisms (SNPs) on the same chromosomal
region, may impact on a complex disease or trait in a different
way from what individual alleles do (Judson et al., 2000; Bader,
2001; Rha et al., 2007). Computer simulation also demonstrates
that haplotype analysis involvingmultiple SNPsmaybemore pow-
erful than single SNP analysis (Collins et al., 1997;Akey et al., 2001;
Morris and Kaplan, 2002; Zaykin et al., 2002). Before current array
technologies can directly genotype haplotypes,wewill always need
a computational algorithm to estimate haplotype effects and vari-
ation based on a statistical mixture model (Liu et al., 2004; Huang
et al., 2007).
The motivation of this article is to develop a general proce-
dure for testing epistasis expressed at the haplotype level and its
genetic components in genetic association studies. Lin and Wu
(2006) developed amodel for testing epistatic effects of haplotypes
derived from the same genome on quantitative traits. This model
was extended to study two-way interactions betweendifferent hap-
lotypes expressed at the host genome and tumor genome in cancer
research (Li and Wu, 2009) and three-way interactions among dif-
ferent haplotypes from the viral genome, transmitter genome, and
recipient genome in infectious disease studies (Li et al., 2009). In
this article,we combine these well developed haplotype-haplotype
interaction models into a case-control design to test and charac-
terize how different components of epistasis exert genetic effects
on a complex disease. We extend this new procedure to allow a
genome-wide search for the distribution and magnitude of epista-
tic interactions and gene-environment interactions expressed at
the haplotype level through the genome. Unlike likelihood-based
approaches proposed by Lake et al. (2003) and Lin and Zeng
(2006), our proposed method is based on stratiﬁed contingency
tables. By analyzing a real data set from the Cleveland Clinic Sar-
coidosis project, the new model identiﬁed signiﬁcant haplotype-
expressed epistasis for sarcoidosis. The statistical behavior of the
new model was tested and validated through simulation studies.
2. METHODS
2.1. STUDY DESIGN
We assume that a natural human population is at Hardy-Weinberg
equilibrium (HWE), from which two groups of samples were
drawn at random. The ﬁrst group includes M cases who dis-
play a disease, and the second group includes N controls with
no disease. It is assumed that cases and controls are matched
for potentially important covariates such as age, sex, ethnicity,
geographical location, environmental factors, etc. All the cases
and controls are genotyped for a panel of SNPs from different
haplotype blocks.
Let us ﬁrst consider two SNPs A and B from block 1 and two
SNPs C and D from block 2, with the capital letters A, B, C, and
D standing for major alleles and small letters a, b, c, and d for
minor alleles at the corresponding SNPs. The four SNPs form a
total of 81 genotypes. Let j1, j2, k1, and k2 denote the genotypes
at SNPs A, B, C, and D, respectively, at each of which there are
three genotypes denoted by 0, 1, and 2. These values stand for the
homozygote of the minor allele, the heterozygote of the minor and
major alleles, and the homozygote of the major allele, respectively;
for example, j1 = 0 for aa, 1 for Aa, and 2 for AA at SNP A. Let
mj1j2k1k2 and nj1j2k1k2 denote the numbers of the observations of
four-SNP genotypes j1 at SNP A and j2 at SNP B from block 1 and
k1 at SNP C and k2 at SNP D from block 2 in cases and controls,
respectively. From the observations of four-SNP genotypes from
two blocks, we calculate the marginal observations of two-SNP
genotypes from each block, which are expressed as
mj1j2·· =
2∑
k1=0
2∑
k2=0
mj1j2k1k2 ,
nj1j2·· =
2∑
k1=0
2∑
k2=0
nj1j2k1k2 , for block 1
m··k1k2 =
2∑
j1=0
2∑
j2=0
mj1j2k1k2 ,
n··k1k2 =
2∑
j1=0
2∑
j2=0
nj1j2k1k2 , for block 2
A model will be developed to detect and test the effects on dis-
ease of haplotypes from each block and the interactions between
different haplotypes from two blocks in the case-control study.
2.2. DETECTING RISK HAPLOTYPE
2.2.1. Estimation of haplotype frequencies
Let us ﬁrst consider two SNPs from block 1. In a recent book
by Wu and Lin (2008), the EM algorithm with a closed form is
given to estimate haplotype frequencies from unphased genotypic
data. In our case, the complete data are the diplotype (haplo-
type) and disease status, but the observed data are genotypes
and disease status, thus the missing data is the connection from
genotypes to diplotypes (haplotypes). If subject i is a double het-
erozygote, A1A2B1B2, it may be one and only one of the two
possible diplotypes. We use
ψ11 = PAB|ab
PAB|ab + PAb|aB and ψ10 =
QAB|ab
QAB|ab + QAb|aB (1)
to denote the proportion of diplotype AB|ab in the total amount
of double heterozygote AaBb in cases and controls, respectively.
Note AB|ab and Ab|aB denote two underlying diplotypes for
genotype AaBb, where the vertical lines separate two chromo-
somes each derived from a different parent. Under HWE, the
frequency of a diplotype is expressed as the product of frequencies
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of the two haplotypes that constitute the diplotype. Thus, we have
PAB|ab = pABpab and PAb|aB = pAbpaB for cases and QAB|ab = qABqab
and QAb|aB = qAbqaB for controls, where pAB, pAb, paB, and pab
are the haplotype frequencies for cases and qAB, qAb, qaB, and qab
are the haplotype frequencies for controls. The EM algorithm is
implemented to separate these twodiplotypes from thedouble het-
erozygote genotypes. In the E step, the proportion of one diplotype
accounting for the double heterozygote in cases and controls are
calculated using equation (1). In theM step, haplotype frequencies
are estimated respectively, using the following formulas:
pAB = 1
2M (2m22 + m21 + m12 + m11ψ11) ,
qAB = 1
2N (2n22 + n21 + n12 + n11ψ10),
pAb = 1
2M (2m20 + m21 + m10 + m11 (1 − ψ11)) ,
qAb = 1
2N (2n20 + n21 + n10 + n11 (1 − ψ10)),
paB = 1
2M (2m02 + m01 + m12 + m11 (1 − ψ11)) ,
qaB = 1
2N (2n02 + n01 + n12 + n11 (1 − ψ10)),
pab = 1
2M (2m00 + m01 + m10 + m11ψ11) ,
qab = 1
2N (2n00 + n01 + n10 + n11ψ10) ,
(2)
where mj1j2 = mj1j2·· and nj1j2 = nj1j2·· (j1, j2 = 0, 1, 2). The E and
M steps are iterated between equations (1) and (2), leading to the
maximum likelihood estimates of haplotype frequencies in cases
and controls, respectively.
Four possible haplotypes,AB,Ab, aB, and ab of these two SNPs
may perform differently in association with the disease. Yet, for
simplicity, we assume that one haplotype is distinct from the
remaining three. Lin and Wu (2006) called this distinct haplo-
type the risk haplotype (denoted by R1) and the remaining the
non-risk haplotype (denoted by R0). Wu et al. (2007) extended
this assumption to handle any number of risk haplotypes and
implemented a model selection criterion to select an optimal risk
haplotype(s) from a given data set. The risk and non-risk hap-
lotypes combine randomly to form three composite diplotypes,
R1R1, R1R0, and R0R0. If these composite diplotypes function
differently, it suggests that two SNPs A and B affect a disease in
a unit of haplotypes. Without loss of generality, we ﬁrst assume
that AB is the risk haplotype and then the composite diplotypes
for each genotype are formed as in Table 1, where observations in
cases and controls are also given. Table 2 tabulates the counts of
composite diplotypes in cases and controls, respectively, after the
genotypes of the same composite diplotypes are added together.
2.2.2. Test and estimation of haplotype effects
The overall haplotype effect due to risk haplotypeAB can be tested
by analyzing a 2× 3 contingency table (Table 2) using a simple χ2
approach with df = 2. Let π r denote the proportion of cases car-
rying a given composite diplotype r (r = 2 for R1R1, 1 for R1R0,
and 0 for R0R0). The expectation for this proportion is related to
the penetrance of that composite diplotype, with the extent being
dependent on the number of cases and controls and the popu-
lation prevalence of the disease (North et al., 2005). We apply a
logistic model to test and estimate the haplotype effect,
log
πr
1 − πr = μr , (3)
where μr denotes the genetic value of a composite diplotype.
Following quantitative genetics principle (Mather and Jinks,
1982), the genetic value of a composite diplotype is expressed
as μ2 =μ+ a for R1R1, μ1 =μ+ d for R1R0, and μ0 =μ− a
for R0R0 where μ, a, and d are the overall mean, the additive
effect and the dominance effect of the risk haplotype, respectively.
Thus, the model (3) can be parameterized in terms of additive and
dominance effects at each SNP and their interactions.
By simple algebra, we have
a = 1
2
(μ2 − μ0) = 1
2
log OR2,0
d = μ1 − 1
2
(μ2 + μ0) = 1
2
(
log OR1,2 + log OR1,0
)
,
(4)
where ORr1,r2 denotes the disease odds ratio of composite diplo-
type r1 vs. composite diplotype r2 (r1, r2 = 2, 1, 0). Let aˆ and dˆ are
Table 1 | Frequencies of 2-SNP genotypes at block 1 calculated from genotypic observations for 2 SNPs at block 1 in both cases and controls.
The composite diplotypes (CD) of each genotype are also given assuming that AB is the risk haplotype.
Genotype AABB AABb AAbb AaBB AaBb Aabb aaBB aaBb aabb
CD R1R1 R1R0 R0R0 R1R0 R1R0 R0R0 R0R0 R0R0 R0R0 R0R0
Cases m22·· m21·· m20·· m12·· m11·· m10·· m02·· m01·· m00··
Controls n22·· n21·· n20·· n12·· n11·· n10·· n02·· n01·· n00··
Table 2 | Frequencies of composite diplotypes for 2 SNPs at block 1 in both cases and controls assuming thatAB is the risk haplotype.
Disease status R1R1 (r =2) R1R0 (r =1) R0R0 (r =0)
Cases m2 =m22·· m1 =m21·· +m12·· +ψ11m11·· m0 =m20·· + (1−ψ11)m11·· +m10·· +m02·· +m01·· +m00··
Controls n2 =n22·· n1 =n21·· +n12·· +ψ10n11·· n0 =n20·· + (1−ψ11)n11·· +n10·· +n02·· +n01·· +n00·
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themaximum likelihood estimates (MLEs) of a and d, respectively.
Note that aˆ and dˆ asymptotically follow a normal distribution,
aˆ
d−→ N
(
a,
1
4
(
1
m2
+ 1
m0
+ 1
n2
+ 1
n0
))
dˆ
d−→ N
(
d ,
1
4
(
1
m2
+ 4
m1
+ 1
m0
+ 1
n2
+ 4
n1
+ 1
n0
))
.
(5)
Appendix A gives detailed derivations. By equation (5), we are not
only be able to test the existence of additive (H 0:a = 0) and dom-
inance effects (H 0:d = 0) by a z-test separately, but also be able to
obtain their estimates.
In practice, a true risk haplotype is unknown. We may assign
each of all possible haplotypes as a risk haplotype and then calcu-
late test statistics in each case. An optimal risk haplotype is chosen,
if it corresponds to the smallest false positive report probability
(FPRP; Wacholder et al., 2004), expressed as
FPRP = 1
1 + prior probability1−prior probability × powerp-value
As can be seen, the FPRP is not only determined by the observed
p-value, but also depends on both the prior probability that the
association between the genetic variant and disease is real and
the statistical power of the test. It reﬂects the probability of no
true association between a genetic variant and disease given that
a signiﬁcant association is found. Here, we assume that all haplo-
types have an equal chance to be the risk haplotype, thus choosing
the smallest FPRP values is equivalent to choosing the smallest
value of ratio between p-value and the power of the test. A similar
procedure can be used to detect the risk haplotype and estimate
haplotype effects for two SNPs from block 2.
2.3. TESTING EPISTASIS EFFECTS BETWEEN TWO BLOCKS
The interactions of haplotypes between two different blocks are
modeled as follows. Without loss of generality, we assume that AB
and CD are the risk haplotypes (R1) and (S1) for block 1 and 2,
respectively, whereas the rest are the non-risk haplotypes, denoted
as R0 (Ab, aB, ab) for block 1 and S0 (Cd, cD, cd) for block 2. Three
composite diplotypes from one block are combined to those from
the second block to form nine across-block composite diplotypes
with observations tabulated in Table 3. Table A1 in Appendix
gives the detailed counts only for cases, with a similar table can be
obtained for controls. In these tables, the relative proportions of a
particular diplotype in the total amount of a double heterozygote
are expressed as
Cases ψ11 = PAB|ab
PAB|ab + PAb|aB , ψ21 =
PCD|cd
PCD|cd + PCd|cD ;
Controls ψ10 = QAB|ab
QAB|ab + QAb|aB , ψ20 =
QCD|cd
QCD|cd + QCd|cD .
The frequency of a diplotype is expressed as the product of
haplotype frequencies under HWE. Haplotype frequencies can be
estimated by implementing the EM algorithm proposed in the
previous section for each block. However, there are two cases here:
(1) the two blocks are independent, and (2) the two blocks are
not independent with linkage disequilibria of different orders. Wu
and Lin (2008) provided the EM algorithm to estimate haplotype
frequencies in each of these two cases. The overall effect of two
haplotypes from two blocks can be tested using a 2× 9 contin-
gency table (Table 3) based on a simple χ2 test with df = 8. The
estimation of haplotype effects including interactions is based on
a logistic model
log (πrs/ (1 − πrs)) = μrs , (6)
where π rs is the proportion of subjects carrying a given across-
block composite diplotype rs (r = 2 for R1R1, 1 for R1R0, and
0 for R0R0 at block 1 and s= 2 for S1S1, 1 for S1S0, and 0 for
S0S0 at block 2) who are cases rather than controls. Mather and
Jinks’ (1982) model is used to describe the genotypic values of a
across-block composite diplotype, μrs’s, as described in Table 4.
Table 3 | Frequencies of across-block composite diplotypes in both cases and controls, assuming thatAB is the risk haplotype for block 1 and
CD is the risk haplotype for block 2.
Disease status Composite diplotype Total
R1R1 R1R1 R1R1 R1R0 R1R0 R1R0 R0R0 R0R0 R0R0
S1S1 S1S0 S0S0 S1S1 S1S0 S0S0 S1S1 S1S0 S0S0
(22) (21) (20) (12) (11) (10) (02) (01) (00)
Cases M22 M21 M20 M12 M11 M10 M02 M01 M00 M
Controls N 22 N 21 N 20 N 12 N 11 N 10 N 02 N 01 N 00 N
Table 4 |The genotypic values of across-block composite diplotypes in terms of additive and dominant effects at each block and interactions
between two blocks.
S1S1 S1S0 S0S0
R1R1 μ22 =μ+ a1 + a2 + iaa μ21 =μ+ a1 +d2 + iad μ20 =μ+ a1 − a2 + iaa
R1R0 μ12 =μ+d1 + a2 + ida μ11 =μ+d1 +d2 + idd μ10 =μ+d1 − a2 + ida
R0R0 μ02 =μ− a1 + a2 − iaa μ01 =μ− a1 +d2 − iad μ00 =μ− a1 − a2 + iaa
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LetORr1s1,r2s2 (r1 ≤ r2, s1 ≤ s2 = 2, 1, 0) denote the disease odds
ratio of composite diplotype r1s1 vs. r2s2. By simple algebra, we
have μ= 1/4(μ22 +μ20 +μ02 +μ00) which is the overall mean
(which is, as a nuisance parameter, not one of interest);
a1 = 1
4
(μ22 − μ00 + μ20 − μ02)
= 1
4
[
log OR22,02 + log OR20,00
]
,
(7)
which is the additive genetic effect of haplotypes from block 1;
a2 = 1
4
(μ02 − μ00 − μ20 + μ22)
= 1
4
[
log OR22,20 + log OR02,00
]
,
(8)
which is the additive genetic effect of haplotypes from block 2;
d1 = 1
4
(2μ10 − μ00 − μ20 − μ02 − μ22 + 2μ12)
= 1
4
[
log OR10,00 + log OR10,20 + log OR12,02 + log OR12,22
]
,
(9)
which is the dominance genetic effect of haplotypes from block 1;
d2 = 1
4
(2μ01 − μ00 − μ20 − μ02 − μ22 + 2μ21)
= 1
4
[
log OR01,00 + log OR01,02 + log OR21,20 + log OR21,22
]
,
(10)
which is the dominance genetic effect of haplotypes from block 2;
iaa = 1
4
(μ22 − μ20 − μ02 + μ00)
= 1
4
[
log OR22,02 − log OR20,00
]
,
(11)
Which is the additive× additive genetic effect between the two
blocks;
iad = 1
4
(2μ21 − μ22 − 2μ01 + μ00 − μ20 + μ02)
= 1
4
[
log OR21,22 + log OR21,20 − log OR01,02 − log OR01,00
]
,
(12)
which is the additive× dominance genetic effect between the
blocks;
ida = 1
4
(2μ12 − 2μ10 + μ00 + μ20 − μ02 − μ22)
= 1
4
[
log OR12,22 + log OR12,02 − log OR10,20 − log OR10,00
]
,
(13)
which is the dominance× additive genetic effect between the two
blocks; and
idd = 1
4
(4μ11 + μ00 + μ20 + μ02 + μ22 − 2μ10 − 2μ12
− 2μ01 − 2μ21)
= 1
4
[
log OR11,10 + log OR11,12 + log OR11,01 + log OR11,21
+ log OR00,10 + log OR20,21 + log OR22,12 + log OR02,01
]
,
(14)
which is the dominance× dominance genetic effect between the
two blocks.
We have proved that each of the genetic effects above has an
asymptotical normality property (see Appendix B for a detail).
Therefore, testing each of the effects can be based on a z-test. In
practice, a true risk haplotype combination from two blocks is
determined using a combinatory approach. This approach assigns
any possible haplotype as a risk haplotype for each block. Thus,
there are a total of 16 combinations for risk haplotypes from the
two blocks. Similarly as in the test of the haplotype effect in one
block, an optimal combination of risk haplotype is one that yields
the smallest FPRP values, which is equivalent to the smallest ratio
of p-value versus power for each single hypothesis test.
Extension of the proposed method to multiple SNPs (>2) in
each block is straightforward (see Wu et al., 2007), which could be
easily accomplished by sliding windows. As shown in the follow-
ing section with 7 SNPs in one gene and 11 SNPs from the second
gene, we consider a sliding window of SNP 1–2 in gene 1 with
SNPs 1–2, SNPs 2–3, . . ., SNPs 10–11 in gene 2 sequentially and,
then do the same thing for SNP 2–3, . . ., SNPs 6–7 in gene 1.
2.4. INCORPORATING GENE-ENVIRONMENT INTERACTIONS
It has been widely recognized that environment affects the expres-
sion of genetic effects including epistasis (Lukens and Doe-
bley, 1999; Willett and Burton, 2003). Here, we incorporate
environment effects into our epistasis model to explore addi-
tive× environment and additive× additive× environment inter-
actions in a case-control study. Consider a 1/0 binary environ-
ment (E) factor like gender or smoking status. The environment
is implemented into a stratiﬁed contingency table (Table A2 in
Appendix).
The environment-speciﬁc genotypic value is expressed as
μe,rs = log P(D = 1|composite diplotypes = rs, E = e)
P(D = 0|composite diplotypes = rs, E = e) ,
r , s = 0, 1, 2; e = 0, 1.
As shown in Table A2 in Appendix, the genotypic values can
be dissolved into different components including additive (a1, a2)
and dominant effects (d1, d2) at each block, the environmen-
tal effect ξ , epistatic interactions between two blocks (iaa, iad,
ida, idd), gene-environment interactions expressed by the addi-
tive and dominant effects at each block (ia1ξ , ia2ξ , id1ξ , id2ξ ), and
gene-environment interactions expressed by epistasis (iaaξ , iadξ ,
idaξ , iddξ ). Similarly, each of these parameters can be written in
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a linear combination of μe,rs’s, which is equivalent to a linear
combination of logarithm of disease odds ratios (see Appendix
C). It can be proved that asymptotic normality property with
gene-environment interactions still holds (results not shown).
3. RESULTS
3.1. SARCOIDOSIS DATA
Sarcoidosis is a disease of unknown cause that leads to inﬂamma-
tion (swelling) in the lymph nodes, lungs, liver, eyes, skin, or other
tissues. Like many other complex disease, sarcoidosis is thought
to involve a genetic component (Grunewald, 2008), but genetic
risk factors for sarcoidosis have rarely been assessed in the con-
text of gene-gene interactions. In the sarcoidosis study conducted
in the Cleveland Clinic, ﬁve candidate genes were measured for
both Caucasian and African Americans, which were chosen based
on gene expression data. Speciﬁcally, 89 race-speciﬁc tagging SNPs
for the coding andpromoter regions of the PPAR-gamma,MMP-7,
MMP-9, MMP-12, and ADAMDec1 genes, were genotyped using
the SNPlex platform. Since the patients were all from Northeast
Ohio, we assume that there is no population admixture in the
study population.
To demonstrate how our method works in a real data analy-
sis, we ﬁrst analyzed a cohort of African Americans without
implementing the environment, including 284 sarcoidosis sub-
jects and 240 healthy volunteers recruited at the Cleveland Clinic.
Of all SNPs, 82 passed quality control. We tested the additive,
dominant, and epistasis between different haplotypes from each
pair of ﬁve genes using sliding windows of size= 2. Because of
multiple comparisons involved, we need to adjust for the signif-
icance level detected using false discovery rates (FDR, Benjamini
and Hochberg, 1995) across all pairs of SNPs between the two
genes studied for interaction. We found several signiﬁcant domi-
nant effects due to haplotypes from MMP9 after the adjustment
(Table 5). Figure 1 illustrates the map of additive× dominant
epistatic tests between haplotypes from genes MMP7 and MMP9
using sliding widows. It was found that genomic region from SNP
rs880197 to rs11568819 within MMP7 displays signiﬁcant addi-
tive× dominant epistatic (iad) effects with genomic region from
SNPrs3918249 to rs3918254withinMMP9(p = 0.0085− 0.0004).
After the adjustment for the signiﬁcance level by FDR, iad is
signiﬁcant at p = 0.102− 0.018 (Table 5).
A signiﬁcant iad effect between haplotypes from a pair of SNPs
rs880197 and rs17098318 (MMP7) and a pair of SNPs rs3918249
and rs3918253 (MMP9) operates through risk haplotypes AA
and TT. The negative iad value suggests that composite diplotype
AA|AA at MMP7 combines composite diplotype TT|TT (where
TT are the rest of haplotypes, CC,CT, and TC) at MMP9 to reduce
the sarcoidosis risk. The same pair from MMP7 also exerts a sig-
niﬁcant iad effect with a pair of SNPs rs3918253 and rs3918254
withinMMP9 in a similar way. Like pair rs880197 and rs17098318,
haplotypes from pair rs17098138 and rs11568818 within MMP7
interacts with haplotypes from pairs rs3918249 and rs3918253 as
well as pair rs3918253 and rs3918255 to reduce sarcoidosis risk to
a similar extent. A pair of SNPs rs11568819 and rs11568819 (CA)
within MMP7, displayed a signiﬁcant additive× dominant epista-
tic effect with a pair of SNPs rs3918253 and rs3918254 (CC)within
MMP9. The risk haplotypes detected areCA forMMP7 andCC for
MMP9 and the additive× dominant effect produced by these two
risk haplotypes was estimated as iad = 0.81. The signiﬁcant posi-
tive value of iad suggests that the homozygous composite diplotype
at gene MMP7 CA|CA combines with the heterozygous composite
diplotype at MMP9 CC|CC (where CC are the rest of haplotypes,
CT, TC, and TT) to increase the risk of sarcoidosis.
A conventional method, such as in SNPassoc of R, was used
to analyze SNP-SNP interactions of the same data although only
an overall interaction effect can be tested. It was found that
SNP rs11568819 at MMP7 has a signiﬁcant interaction with SNP
rs3918253 at MMP9 (p = 0.003). This ﬁnding is basically con-
sistent with those from our method, although the latter can be
explained in a physiologically meaningful way.
In the second analysis, we explored how the environment inﬂu-
ences the expression of additive, dominant, and epistatic effects on
Table 5 | Estimation and significance test (corrected for multiple comparisons using FDR) of genetic effects on sarcoidosis risk by haplotypes
composed of SNPs from MMP7 and MMP9.
Effect [MMP7 SNPs][MMP9 SNPs] Risk Hap Risk Hap freq. Est(SD) p FDR
MMP7 MMP9
Case Control Case Control
d2 [rs11568819–rs11568818][rs2250889–rs17577] CA-CG 0.596 0.522 0.678 0.681 1.21(0.35) 0.0006 0.036
[rs11568818–rs17098318][rs4810482–rs3918241] GA-CT 0.364 0.410 0.460 0.519 −0.75(0.27) 0.0059 0.089
[rs11568818–rs17098318][rs2250889–rs17577] AG-CG 0.597 0.521 0.678 0.681 0.94(0.32) 0.0035 0.089
[rs17098318–rs880197][rs4810482–rs3918241] AA-CT 0.365 0.422 0.460 0.519 −0.76(0.27) 0.0045 0.089
iad [rs11568818–rs17098318][rs3918249–rs3918253] AA-TT 0.365 0.422 0.295 0.234 −1.00(0.35) 0.0040 0.080
[rs11568818–rs17098318][rs3918253–rs3918254] AA-CC 0.365 0.422 0.648 0.697 −1.17(0.33) 0.0004 0.018
[rs17098318-rs880197][rs3918249–rs3918253] GA-TT 0.364 0.410 0.295 0.234 −0.96(0.35) 0.0056 0.084
[rs17098318–rs880197][rs3918253–rs3918254] GA-CC 0.364 0.410 0.648 0.697 −1.14(0.33) 0.0006 0.018
[rs11568819–rs11568818][rs3918253–rs3918254] CA-CC 0.596 0.522 0.648 0.697 0.81(0.31) 0.0085 0.102
Risk haplotypes in the two genes and their frequencies in cases and controls are given.
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FIGURE 1 | Pairwise significance tests of additive×dominant epistasis between 7 SNPs at MMP7 and 11 SNPs at MMP9 in a genetic association
study of sarcoidosis risk.
sarcoidosis risk. We consider smoking status as an environmental
factor. Data analysis based on Table 5 suggests that smoking status
displays a signiﬁcant interaction (p = 0.0005) with the dominant
effect triggered by a haplotype of SNPs rs9650409 and rs12334642
(ADAMDEC1), with the estimated interaction value id2ξ = 1.63
and SE= 0.47. However, this result should be interpreted with
caution because 30% of the subjects have no smoking information
and, thus, were excluded from our analysis.
3.2. SIMULATION STUDY
We performed simulation studies to investigate the power and
Type I error rate of epistatic detection by our model. Two inde-
pendent haplotype blocks were simulated, each composed of two
SNPs. A natural population at HWE with the prevalence of dis-
ease= 0.35% was ﬁrst generated, from which 250 cases and 250
controls (or 500 cases and 500 controls) were randomly selected.
The ﬁrst two scenarios of simulation were used to evaluate the
power and precision of the estimation, and the last one is to assess
the Type I error rate under the null model of no interactions:
• Scenario 1: mimicking SNPs rs11568819–rs11568818 at MMP7
and SNPs rs3918253–rs3918254 at MMP9 with a signiﬁcant
epistatic effect of iad;
• Scenario 2: mimicking SNPs rs11568818–rs17098318 at MMP7
and SNPs rs4810482–rs3918241 at MMP9 with signiﬁcant
genetic effects of d2 and idd.
• Scenario 3: mimicking SNPs rs11568819–rs11568818 at MMP7
and SNPs rs3918253–rs3918254 at MMP9 without any signiﬁ-
cant epistatic effects, i.e., iaa = iad = ida = idd = 0.
Haplotype frequencies, risk haplotypes, and other genetic effects
used for the simulation were their MLEs from the real data at the
corresponding SNPs. Simulation results basedon1000 simulations
are summarized in Tables A3–A5 in Appendix.
In general, our method provides reasonably precise estimates
for all genetic effects parameterswith small biases andMSEs (mean
squared errors) even when a moderate sample size is used. How-
ever, if the study is aimed to estimate additive effects of haplotypes,
250 cases and250 controls should be adequately enough to get con-
vincing results. If we are interested in the estimation of dominant
effects and their interactions with other effects, 500 cases and 500
controls are recommended. We also analyzed the power of our
model based on 1000 simulations at the signiﬁcance level of 0.05.
In Scenario 1, the power of detecting the additive× dominant
effect is 0.72 for 250 cases and 250 controls and increases to
0.96 for doubled sample sizes. To compare with existing mod-
els, we use SNPassoc, R, to estimate the power of interaction
detection, which is much lower than our method (Table A3 in
Appendix). In Scenario 2 with one more signiﬁcant effect, similar
results of power were detected, although the comparison between
our method and existing approach is more sharply contrast rel-
ative to Scenario 1. Scenario 3 shows that the Type I error rates
are comparative (around 0.05) comparing with the conventional
SNP-SNP interaction method (around 0.2) and, as expected, the
Type I error rate does not depend on sample sizes (Table A5 in
Appendix).
4. DISCUSSION
By dissecting epistasis into its different components according to
traditional quantitative genetic theory (Mather and Jinks, 1982),
we develop a new model for detecting haplotype-haplotype inter-
actions in case-control studies via population-based sampling. The
model was founded on two bodies of increasingly proven evidence
that the genetic variation of complex traits arises from haplotype
diversity and effects (Judson et al., 2000; Bader, 2001; Rha et al.,
2007) and genetic interactions (Marchini et al., 2005; North et al.,
2005; Purcell et al., 2007; An et al., 2009; Lambrechts, 2010; Wang
et al., 2010;Wray and Goddard, 2010;Wu et al., 2010). The advan-
tage of the new model is not only a simple combination of the
power of haplotype analysis and epistatic modeling, but also lies
in its capacity to provide more genetic meaningful explanations
and conclusions for a given data set.
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Liu et al. (2011) provided an elegant proof for the asymptotic
property of epistatic detection at the individual gene level from a
contingency table. This property greatly enhances the computing
efﬁciency of epistatic testing throughout the genome and also dis-
plays greater power to detect epistasis for additive× dominant,
dominant× additive, and dominant× dominant components,
compared with conventional log-logistic models. In this arti-
cle, the statistical property proven at the gene level is found to
hold for epistatic identiﬁcation at the haplotype level. This con-
sistency greatly facilitates the practical usefulness of our new
model to characterize genetic interactions that occur between
haplotypes derived from chromosomal segments.When this prop-
erty is used to study genome-genome interactions (Li and Wu,
2009; Li et al., 2009), we will be able to dictate a comprehen-
sive picture of the genetic architecture of complex diseases and
pathogenesis.
Although our derivation focuses on two genome blocks in a
genome, we are currently working to expand this model into a
genome-wide association study in which all possible pairs of hap-
lotype interactions can be detected and tested. Li et al. (2011) have
used a lasso model to detect signiﬁcant genetic variants from high-
dimension genetic data through penalized regression. A similar
line of model selection can be implemented into our case-control
design aimed to detect signiﬁcant haplotype-haplotype interac-
tions. The determination of an optimal length of haplotypemay be
an issue. Yet, our model is ﬂexible to include any number of SNPs
for haplotype analysis. As shown in Li et al. (2006), an increasing
number of disequilibriumparameters expressed at different orders
will need to be modeled when multiple SNPs are included, which
may prohibit computation. A cluster of paralleled machines can
be deployed to accelerate analysis and discrimination processes of
haplotype-haplotype interactions.
Our model was built on a two-SNP haplotype assumption.
The idea presented can be readily extended to include an arbi-
trary number of SNPs with no technical difﬁculty. For L1 SNPs
in gene one, there are 2L1 haplotype. But we can still assume one
risk haplotype that is combined with 2L1 − 1 non-risk haplotypes
to generate three composite diplotypes. When gene two with L2
SNPs is also considered, we will still have nine composite diplo-
types. However, the selection of an optimal combination of risk
haplotypes at the two genes will be made from 2(L1 + L2) haplotype
combinations. It should be pointed out that there will be lower
numbers in some cells of the contingency table when long hap-
lotype are modeled. To make our normality assumption a case in
this situation, we need to determine the maximum length of hap-
lotypes which can be reasonably used to identify the risk haplotype
for a given sample size.
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APPENDIX
A. TWO-SNP HAPLOTYPE IN BLOCK 1
Let us ﬁrst consider the case-control data of two SNPs from block 1, assuming AB is the risk haplotype. In a case-control study, we have
m and n random samples drawn from the case group and the control group, respectively. The data can be summarized in the following
table
Disease status (D) Composite diplotype Total
R1R1 (r =2) R1R0 (r =1) R0R0 (r =0)
Cases m2 m1 m0 m
Controls n2 n1 n0 n
where mr an nr are the observed counts of composite diplotype r = 2, 1, 0 for cases and controls, respectively.
pdr = P(Composite diplotype= r |D = d), d = 1 (cases) and 0 (controls); r = 2, 1, 0. For examples p12 = P(R1R1|Cases),
p00 = P(R0R0|Controls).
By the result on Page 150 of Agresti’s book (Agresti, 2002), we know
√
m
(
pˆ1 − p1
) d−→ N (0, diag (p1)− p1 p′1) ,
√
n
(
pˆ0 − p0
) d−→ N (0, diag (p0)− p0 p′0) ,
(A1)
where p1 = (p12, p11, p10)′, p0 = (p02, p01, p00)′ and
pˆ1 =
(
pˆ12, pˆ11, pˆ10
)′ = (m2
m
,
m1
m
,
m0
m
)′
,
pˆ0 =
(
pˆ02, pˆ01, pˆ00
)′ = (n2
n
,
n1
n
,
n0
n
)′
.
Please note that pˆ1 and pˆ0 are independent.
By using the multivariate Delta method, we get
√
m
(
log
(
pˆ1
)− log (p1)) d−→ N (0, [diag (p1)]−1 − 131′3) ,
√
n
(
log
(
pˆ0
)− log (p0)) d−→ N (0, [diag (p0)]−1 − 131′3) ,
(A2)
where 13 is the 3-dimension vector with each entry being 1.
A.1. THE ASYMPTOTIC NORMALITY OF ADDITIVE EFFECT a
Recall that a = 1/2(log OR2,0), i.e.,
a = 1
2
log
P (Cases|R1R1) /P (Controls|R1R1)
P (Cases|R0R0) /P (Controls|R0R0)
= 1
2
log
P (R1R1|Cases) /P (R1R1|Controls)
P (R0R0|Cases) /P (R0R0|Controls)
= 1
2
log
p12/p10
p02/p00
.
The MLE of a is aˆ = 12 [(log pˆ12 − log pˆ10) − (log pˆ02 − log pˆ00)] with the asymptotic (1−α)100% conﬁdence interval
aˆ ± zα/2 × 1
2
√
1
m2
+ 1
m0
+ 1
n2
+ 1
n0
.
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A.2. THE ASYMPTOTIC NORMALITY OF DOMINANCE EFFECT d
Recall the dominance effect d is deﬁned as 1/2(logOR1,2 + logOR1,0), the MLE of d is
dˆ = 1
2
[
log pˆ11 − log pˆ12 + log pˆ11 − log pˆ10
]
− 1
2
[
log pˆ21 − log pˆ22 + log pˆ21 − log pˆ20
]
.
with the asymptotic (1−α)100% conﬁdence interval
dˆ ± zα/2 × 1
2
√
1
m2
+ 4
m1
+ 1
m0
+ 1
n2
+ 4
n1
+ 1
n0
.
B. EPISTASIS EFFECTS BETWEEN TWO BLOCKS
Now let’s think about the more complicated cases – testing epistasis effects between two blocks. The data can be summarized in the
following table,
Disease status Composite diplotype Total
R1R1 R1R1 R1R1 R1R0 R1R0 R1R0 R0R0 R0R0 R0R0
S1S1 S1S0 S0S0 S1S1 S1S0 S0S0 S1S1 S1S0 S0S0
(22) (21) (20) (12) (11) (10) (02) (01) (00)
Cases M22 M21 M20 M12 M11 M10 M02 M01 M00 M
Controls N 22 N 21 N 20 N 12 N 11 N 10 N 02 N 01 N 00 N
whereMrs andN rs are the observed counts of composite diplotype rs for cases and controls, respectively.
Let pd,rs = P(Composite type= rs|Disease= d), d = 1, 0; rs = 22, 21, 20, 12, 11, 10, 02, 01, 00. For examples
p1,22 = P(R1R1S1S1|Cases), p0,00 = P(R0R0S0S0|Controls).
From previous results, we can ﬁnd that
log ORr1s1,r2s2 =
(
log p1,r1s1 − log p1,r2s2
)− (log p0,r1s1 − log p0,r2s2) ,
where r1s1 and r2s2 indicate two different composite diplotypes.
Let
p1 =
(
p1,22, p1,21, p1,20, · · · , p1,02, p1,01, p1,00
)′
,
p0 =
(
p0,22, p0,21, p0,20, · · · , p0,02, p0,01, p0,00
)′
,
pˆ1 =
(
pˆ1,22, pˆ1,21, pˆ1,20, · · · , pˆ1,02, pˆ1,01, pˆ1,00
)′
,
pˆ0 =
(
pˆ0,22, pˆ0,21, pˆ0,20, · · · , pˆ0,02, pˆ0,01, pˆ0,00
)′
,
where pˆ1,rs = MrsM and pˆ0,rs = NrsN .
B.1. THE ASYMPTOTIC NORMALITY OF EFFECT a1
Recall that a1 = 1/4[logOR22,02 + logOR20,00]. The MLE of a1 is
aˆ1 = 1
4
[
log pˆ1,22 − log pˆ1,00 + log pˆ1,20 − log pˆ1,02
]
− 1
4
[
log pˆ0,22 − log pˆ0,00 + log pˆ0,20 − log pˆ0,02
]
.
with the asymptotic (1−α)100% conﬁdence interval of a1 is
aˆ1 ±zα/2 × 1
4
√
1
M 22 +
1
M 20 +
1
M 02 +
1
M 00 +
1
N 22 +
1
N 20 +
1
N 02 +
1
N 00.
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B.2. THE ASYMPTOTIC NORMALITY OF EFFECT a2
Recall that a2 = 1/4[logOR22,20 + logOR02,00]. Similarly, the MLE of a2 is
aˆ2 = 1
4
[
log pˆ1,22 − log pˆ1,00 + log pˆ1,02 − log pˆ1,20
]
− 1
4
[
log pˆ0,22 − log pˆ0,00 + log pˆ0,02 − log pˆ0,20
]
.
with the asymptotic (1−α)100% conﬁdence interval of a2 is
aˆ2 ±zα/2 × 1
4
√
1
M 22 +
1
M 20 +
1
M 02 +
1
M 00 +
1
N 22 +
1
N 20 +
1
N 02 +
1
N 00.
B.3. THE ASYMPTOTIC NORMALITY OF EFFECT d 1
Recall that
d1 = 1
4
[
log OR10,00 + log OR10,20 + log OR12,02 + log OR12,22
]
.
The MLE of d1 is
dˆ1 = 1
4
[
2 log pˆ1,10 − log pˆ1,00 − log pˆ1,20 +2 log pˆ1,12 − log pˆ1,02 − log pˆ1,22
]
− 1
4
[
2 log pˆ0,10 − log pˆ0,00 − log pˆ0,20 +2 log pˆ0,12 − log pˆ0,02 − log pˆ0,22
]
.
with the asymptotic (1−α)100% conﬁdence interval of d1 is
dˆ1 ±zα/2 × 1
4
√
1
M 22 +
1
M 20 +
4
M 12 +
4
M 10 +
1
M 02 +
1
M 00 +
1
N 22 +
1
N 20 +
4
N 12 +
4
N 10 +
1
N 02 +
1
N 00.
B.4. THE ASYMPTOTIC NORMALITY OF EFFECT d 2
Recall that
d2 = 1
4
[
log OR01,00 + log OR01,02 + log OR21,20 + log OR21,22
]
.
The MLE of d2 is
dˆ2 = 1
4
[
2 log pˆ1,01 − log pˆ1,00 − log pˆ1,02 +2 log pˆ1,21 − log pˆ1,20 − log pˆ1,22
]
− 1
4
[
2 log pˆ0,01 − log pˆ0,00 − log pˆ0,02 +2 log pˆ0,21 − log pˆ0,20 − log pˆ0,22
]
.
the asymptotic (1−α)100% conﬁdence interval of d2 is
dˆ2 ±zα/2 × 1
4
√
4
M 01 +
1
M 00 +
4
M 02 +
4
M 21 +
1
M 20 +
1
M 22 +
4
N 01 +
1
N 00 +
1
N 02 +
4
N 21 +
1
N 20 +
1
N 22.
B.5. THE ASYMPTOTIC NORMALITY OF EFFECT iaa
Recall that
iaa = 1
4
[
log OR22,02 − log OR20,00
]
.
The MLE of iaa is
iˆaa = 1
4
[
log pˆ1,22 − log pˆ1,02 − log pˆ1,20 + log pˆ1,00
]
− 1
4
[
log pˆ0,22 − log pˆ0,02 − log pˆ0,20 + log pˆ0,00
]
,
The asymptotic (1−α)100% conﬁdence interval of iaa is
iˆaa ±zα/2 × 1
4
√
1
M 22 +
1
M 20 +
1
M 02 +
1
M 00 +
1
N 22 +
1
N 20 +
1
N 02 +
1
N 00.
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B.6. THE ASYMPTOTIC NORMALITY OF EFFECT iad
Recall that
iad = 1
4
[
log OR21,22 + log OR21,20 − log OR01,02 − log OR01,00
]
.
The MLE of iad is
iˆad = 1
4
[
2 log pˆ1,21 − log pˆ1,22 − log pˆ1,20 −2 log pˆ1,01 + log pˆ1,02 + log pˆ1,00
]
− 1
4
[
2 log pˆ0,21 − log pˆ0,22 − log pˆ0,20 −2 log pˆ0,01 + log pˆ0,02 + log pˆ0,00
]
.
The asymptotic (1−α)100% conﬁdence interval of iad is
iˆad ±zα/2 × 1
4
√
4
M 21 +
1
M 22 +
1
M 20 +
4
M 01 +
1
M 02 +
1
M 00 +
4
N 21 +
1
N 22 +
1
N 20 +
4
N 01 +
1
N 02 +
1
N 00.
B.7. THE ASYMPTOTIC NORMALITY OF EFFECT ida
Recall that
ida = 1
4
[
log OR12,22 + log OR12,02 − log OR10,20 − log OR10,00
]
.
The MLE of ida is
iˆda = 1
4
[
2 log pˆ1,12 − log pˆ1,22 − log pˆ1,02 −2 log pˆ1,10 + log pˆ1,20 + log pˆ1,00
]
− 1
4
[
2 log pˆ0,12 − log pˆ0,22 − log pˆ0,02 −2 log pˆ0,10 + log pˆ0,20 + log pˆ0,00
]
.
The asymptotic (1−α)100% conﬁdence interval of ida is
iˆda ±zα/2 × 1
4
√
4
M 12 +
1
M 22 +
1
M 02 +
4
M 10 +
1
M 20 +
1
M 00 +
4
N 12 +
1
N 22 +
1
N 02 +
4
N 10 +
1
N 20 +
1
N 00.
B.8. THE ASYMPTOTIC NORMALITY OF EFFECT idd
Recall that
idd = 1
4
[
log OR11,10 + log OR11,12 + log OR11,01 + log OR11,21
+ log OR00,10 + log OR20,21 + log OR22,12 + log OR02,01
]
.
The MLE of idd is
iˆdd = 1
4
[
4 log pˆ1,11 −2 log pˆ1,10 −2 log pˆ1,12 −2 log pˆ1,01 −2 log pˆ1,21
+ log pˆ1,00 + log pˆ1,20 + log pˆ1,22 + log pˆ1,02
]
− 1
4
[
4 log pˆ0,11 −2 log pˆ0,10 −2 log pˆ0,12 −2 log pˆ0,01 −2 log pˆ0,21
+ log pˆ0,00 + log pˆ0,20 + log pˆ0,22 + log pˆ0,02
]
.
The asymptotic (1−α)100% conﬁdence interval of idd is
iˆdd ±zα/2 × σdd ,
where
σdd = 1
4
√
16
M 11 +
4
M 10 +
4
M 12 +
4
M 01 +
4
M 21 +
1
M 00 +
1
M 20 +
1
M 22 +
1
M 02 +
16
N 11 +
4
N 10 + · · · +
1
N 02.
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C. EPISTASIS EFFECTS BETWEEN TWO BLOCKS AND INTERACTIONS BETWEEN HAPLOTYPE AND A BINARY
ENVIRONMENTAL FACTOR
Table A2 presents the genotypic values of 9 across-block composite diplotypes stratiﬁed by a binary environmental factor (E = 0, 1).
As shown in below, each parameter can be written in a linear combination of μe,rs’s, which is equivalent to a linear combination of
logarithm of disease odds ratios, i.e.,
μ = 1
8
1∑
e=0
(
μe,22 + μe,20 + μe,02 + μe,00
)
a1 = 1
8
1∑
e=0
(
μe,22 − μe,00 + μe,20 − μe,02
) = 1
8
1∑
e=0
[
log ORe,22,02 + log ORe,20,00
]
a2 = 1
8
1∑
e=0
(
μe,02 − μe,00 − μe,20 + μe,22
) = 1
8
1∑
e=0
[
log ORe,22,20 + log ORe,02,00
]
d1 = 1
8
1∑
e=0
(
2μe,10 − μe,00 − μe,20 − μe,02 − μe,22 + 2μe,12
)
= 1
8
1∑
e=0
[
log ORe,10,00 + log ORe,10,20 + log ORe,12,02 + log ORe,12,22
]
d2 = 1
8
1∑
e=0
(
2μe,01 − μe,00 − μe,20 − μe,02 − μe,22 + 2μe,21
)
= 1
8
1∑
e=0
[
log ORe,01,00 + log ORe,01,02 + log ORe,21,20 + log ORe,21,22
]
iaa = 1
8
1∑
e=0
(
μe,22 − μe,20 − μe,02 + μe,00
) = 1
8
1∑
e=0
[
log ORe,22,02 − log ORe,20,00
]
iad = 1
8
1∑
e=0
(
2μe,21 − μe,22 − 2μe,01 + μe,00 − μe,20 + μe,02
)
= 1
8
1∑
e=0
[
log ORe,21,22 + log ORe,21,20 − log ORe,01,02 − log ORe,01,00
]
ida = 1
8
1∑
e=0
(
2μe,12 − 2μe,10 + μe,00 + μe,20 − μe,02 − μe,22
)
= 1
8
1∑
e=0
[
log ORe,12,22 + log ORe,12,02 − log ORe,10,20 − log ORe,10,00
]
idd = 1
8
1∑
e=0
(
4μe,11 + μe,00 + μe,20 + μe,02 + μe,22 − 2μe,10 − 2μe,12 − 2μe,01 − 2μe,21
)
= 1
8
1∑
e=0
[
log ORe,11,10 + log ORe,11,12 + log ORe,11,01 + log ORe,11,21
+ log ORe,00,10 + log ORe,20,21 + log ORe,22,12 + log ORe,02,01
]
ξ = 1
8
1∑
e=0
(−1)1−e (μe,22 + μe,20 + μe,02 + μe,00) = 1
8
(or22 + or20 + or02 + or00)
ia1ξ =
1
8
1∑
e=0
(−1)1−e (μe,22 − μe,00 + μe,20 − μe,02) = 1
8
1∑
e=0
(−1)1−e [log ORe,22,02 + log ORe,20,00]
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ia2ξ =
1
8
1∑
e=0
(−1)1−e (μe,02 − μe,00 − μe,20 + μe,22) = 1
8
1∑
e=0
(−1)1−e [log ORe,22,20 + log ORe,02,00]
id1ξ =
1
8
1∑
e=0
(−1)1−e (2μe,10 − μe,00 − μe,20 − μe,02 − μe,22 + 2μe,12)
= 1
8
1∑
e=0
(−1)1−e [log ORe,10,00 + log ORe,10,20 + log ORe,12,02 + log ORe,12,22]
id2ξ =
1
8
1∑
e=0
(−1)1−e (2μe,01 − μe,00 − μe,20 − μe,02 − μe,22 + 2μe,21)
= 1
8
1∑
e=0
(−1)1−e [log ORe,01,00 + log ORe,01,02 + log ORe,21,20 + log ORe,21,22 ]
ORe,r1s1,r2s2(r1, r2, s1, s2 = 2, 1, 0) denotes the disease odds ratio of composite diplotype r1s1 vs. r2s2 given a ﬁxed e = 0, 1. orrs stands
for the disease odds ratio of the environmental factor e = 1 vs. e = 0 given a ﬁxed composite diplotype rs.
Table A1 | Frequencies of across-block composite diplotypes calculated from across-block genotypes in cases, assuming thatAB is the risk
haplotype for block 1 and CD is the risk haplotype for block 2.
S1S1 S1S0 S0S0
R1R1 M22 =m2222 M21 =m2221 +m2212 +
ψ21m2211
M20 =m2220 + (1−ψ21)m2211 +
m2210 +m2202 +m2201 +m2200
R1R0 M12 =m2122 +
m1222 +ψ11n1122
M11 =m2121 +m2112 +
ψ21m2111 +m1221 +m1212 +
i21m1211 +ψ11(m1121 +m1112 +
ψ21m1111)
M10 =m2120 + (1−ψ21)m2111 +m2110 +m2102 +m2101 +m2100 +
m1220 + (1−ψ21)m1211 +m1210 +m1202 +m1201 +m1200 +
ψ11[m1120 + (1−ψ21)m1111 +m1110 +m1102 +m1101 +m1101]
R0R0 M02 =m2022 +
(1−ψ11)m1122 +m1022 +
m0222 +m0122 +m0022
M01 =m2021 +m2012 +
ψ21m2011 + (1− i11)[m1121 +
m1112 +ψ21m1111]+m1021 +
m1012 +ψ21m1011 +m0221 +m0212 +
ψ21m0211 +m0121 +m0112 +ψ21m0111 +
m0021 +m0012 +ψ21m0011
M00 =m2020 + (1−ψ21)m2011 +m2010 +m2002 +
m2001 +m2000 + (1−ψ11)(m1120 + (1−ψ21)m1111 +m1110)+
m1102 +m1101 +m1100 +m1020 + (1−ψ21)m1011 +m1010 +m1002 +
m1001 +m1000 +m0220 + (1−ψ21)m0211 +m0210 +m0202 +
m0201 +m0200 +m0120 + (1−ψ21)m0111 +m0110 +m0102 +m0101 +
m0100 +m0020 + (1−ψ21)m0011 +m0010 +m0002 +m0001 +m0000
Table A2 |The genotypic values of 9 across-block composite diplotypes stratified by a binary environmental factor (E =0, 1).
Environ. factor Composite diplotype S1S1 (s =2) S1S0 (s =1) S0S0 (s =0)
E =0 R1R1 (r =2) μ0,22 = μ + a1 + a2 − ξ+iaa − ia1ξ − ia2ξ − iaaξ
μ0,21 = μ + a1 + d2 − ξ
+iad − ia1ξ − id2ξ − iadξ
μ0,20 = μ + a1 − a2 − ξ
−iaa − ia1ξ + ia2ξ + iaaξ
R1R0 (r =1) μ0,12 = μ + d1 + a2 − ξ+ida − ia2ξ − id1ξ − idaξ
μ0,11 = μ + d1 + d2 − ξ
+idd − id1ξ − id2ξ − iddξ
μ0,10 = μ + d1 − a2 − ξ
−ida + ia2ξ − id1ξ + idaξ
R0R0 (r =0) μ0,02 = μ − a1 + a2 − ξ−iaa + ia1ξ − ia2ξ + iaaξ
μ0,01 = μ − a1 + d2 − ξ
−iad + ia1ξ − id2ξ + iadξ
μ0,00 = μ − a1 − a2 − ξ
+iaa + ia1ξ + ia2ξ − iaaξ
E =1 R1R1 (r =2) μ1,22 = μ + a1 + a2 + ξ+iaa + ia1ξ + ia2ξ + iaaξ
μ1,21 = μ + a1 + d2 + ξ
+iad + ia1ξ + id2ξ + iadξ
μ1,20 = μ + a1 − a2 + ξ
−iaa + ia1ξ − ia2ξ − iaaξ
R1R0 (r =1) μ1,12 = μ + d1 + a2 + ξ+ida + ia2ξ + id1ξ + idaξ
μ1,11 = μ + d1 + d2 + ξ
+idd + id1ξ + id2ξ + iddξ
μ1,10 = μ + d1 − a2 + ξ
−ida − ia2ξ + id1ξ − idaξ
R0R0 (r =0) μ1,02 = μ − a1 + a2 + ξ−iaa − ia1ξ + ia2ξ − iaaξ
μ1,01 = μ − a1 + d2 + ξ
−iad − ia1ξ + id2ξ − iadξ
μ1,00 = μ − a1 − a2 + ξ
+iaa − ia1ξ − ia2ξ + iaaξ
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Table A3 | Estimation of genetic parameters and power of epistatic detection from a simulated data for two independent blocks under Scenario
1 for all 1000 simulations.
Parameter True 250 Cases/250 controls 500 Cases/500 controls
Est MSE Power Est MSE Power
a1 −0.125 −0.123 0.061 −0.120 0.028
a2 −0.275 −0.301 0.062 −0.293 0.029
d1 −0.485 0.484 0.115 −0.472 0.057
d2 −0.363 −0.392 0.174 −0.374 0.092
iaa −0.125 −0.123 0.062 −0.120 0.028
iad 0.810 0.827 0.110 0.719 0.810 0.050 0.961
ida −0.506 −0.481 0.117 −0.498 0.055
idd 0.301 0.321 0.197 0.296 0.103
S1,1–S2,1* 0.087 0.122
S1,1–S2,2* 0.065 0.074
S1,2–S2,1* 0.129 0.214
S1,2–S2,2* 0.050 0.056
S1,1** 0.081 0.115
S1,2** 0.852 0.996
S2,1** 0.756 0.969
S2,2** 0.244 0.430
S1,i–S2,j*: the power for detecting the interaction between ith SNP in block 1 and jth SNP in block 2 by SNPassoc (R).
Sl,i**: the power for single SNP association study by an existing approach (SNPassoc, R).
Table A4 | Estimation of genetic parameters and power of epistatic detection from a simulated data for two independent blocks under Scenario
2 for all 1000 simulations.
Parameter True 250 Cases/250 controls 500 Cases/500 controls
Est MSE Power Est MSE Power
a1 0.341 0.357 0.053 0.353 0.024
a2 −0.713 −0.735 0.051 −0.725 0.024
d1 −0.459 −0.493 0.117 −0.467 0.051
d2 −0.746 −0.784 0.101 0.731 −0.749 0.044 0.950
iaa 0.341 0.357 0.050 0.353 0.024
iad −0.210 −0.230 0.089 −0.231 0.045
ida −0.499 −0.500 0.104 −0.499 0.050
idd 1.038 1.089 0.202 0.734 1.053 0.083 0.955
S1,1–S2,1* 0.050 0.040
S1,1–S2,2* 0.053 0.057
S1,2–S2,1* 0.042 0.046
S1,2–S2,2* 0.052 0.049
S1,1** 0.365 0.600
S1,2** 0.438 0.715
S2,1** 0.995 1.000
S2,2** 0.696 0.929
S1,i–S2,j*: the power for detecting the interaction between ith SNP in block 1 and jth SNP in block 2 by SNPassoc (R).
Sl,i**: the power for single SNP association study by an existing approach (SNPassoc, R).
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Table A5 |Type I error rate for all epistatic detection of two independent blocks under Scenario 3 for 1000 simulations.
Parameter True 250 Cases/250 controls 500 Cases/500 controls
Est MSE Type I error Est MSE Type I error
iaa 0 −0.127 0.070 0.049 −0.127 0.044 0.050
iad 0 −0.008 0.098 0.054 0.004 0.047 0.048
ida 0 0.019 0.102 0.043 0.007 0.055 0.053
idd 0 0.037 0.188 0.045 0.005 0.093 0.049
S1,1–S2,1* 0.060 0.050
S1,1–S2,2* 0.064 0.043
S1,2–S2,1* 0.060 0.050
S1,2–S2,2* 0.048 0.049
S1,1** 0.050 0.044
S1,2** 0.156 0.235
S2,1** 0.046 0.098
S2,2** 0.062 0.081
S1,i–S2,j*: type I error rate for detecting the interaction between ith SNP in block 1 and jth SNP in block 2 by SNPassoc (R).
Sl,i**: type I error rate for single SNP association study by an existing approach (SNPassoc, R).
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